About Pilot gene technology
Pilot gene technology is a company based in Hangzhou (China) founded in 2017. Pilot gene technology has raised $18.51 million across 1 funding round from investors including Share Capital. Pilot gene technology offers products and services including Digital PCR System and PCR Detection Kits.
- Headquarter Hangzhou, China
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name 领航基因科技（杭州）有限公司
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$18.51 M (USD)
in 1 rounds
-
Latest Funding Round
$18.51 M (USD), Series A
Jul 19, 2021
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pilot gene technology
Pilot gene technology offers a comprehensive portfolio of products and services, including Digital PCR System and PCR Detection Kits.
Digital PCR systems are utilized for pathogen detection in clinical environments, where they are applied to analyze samples for infections
PCR detection kits are employed for rapid testing of conditions like bloodstream infections, where they are integrated into automated systems for efficient results
Funding Insights of Pilot gene technology
Pilot gene technology has successfully raised a total of $18.51M through 1 strategic funding round. The most recent funding activity was a Series A round of $18.51 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $18.5M
-
First Round
First Round
(19 Jul 2021)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Series A - Pilot gene technology | Valuation | Share Capital |
|
Investors in Pilot gene technology
Pilot gene technology has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Share Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A venture capital firm based in Shenzhen, China, is operated.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pilot gene technology
Financial Statements - Pilot gene technology
Pilot Gene Technology Comparisons
Competitors of Pilot gene technology
Latest news on Pilot Gene Technology
Frequently Asked Questions about Pilot gene technology
Pilot gene technology was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Pilot gene technology is headquartered in Hangzhou, China. It is registered at Hangzhou, Zhejiang, China.
Pilot gene technology is a funded company, having raised a total of $18.51M across 1 funding round to date. The company's 1st funding round was a Series A of $18.51M, raised on Jul 19, 2021.
Pilot Gene Technology was established in 2017 and is based in Hangzhou, China. Focus is placed on research and development, production, and supply within the biotechnology sector, specifically digital PCR technologies. Operations involve creating tools for precise genetic quantification and analysis. Products are distributed to support applications in molecular diagnostics and research, with activities centered in the Asia-Pacific region.
Pilot gene technology offers Digital PCR System and PCR Detection Kits.
Pilot gene technology has 1 investor. Key investors include Share Capital.